Addus HomeCare Corp Stock: price and insider trades · United States · SEC (Form 4)Track the Addus HomeCare Corp share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Addus HomeCare Corp has logged 285 public disclosures. Market capitalisation: €2.1bn. The latest transaction was reported on 23 June 2026 (Cession). Among the most active insiders: ALLISON R DIRK. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate Addus HomeCare Corp Buy (bullish), based on 13 analysts. Average price target: US$133.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,042 of 29,062 companies
FCF yld 4.8%
Earn yld 4.4%
EV/EBITDA 14.8x
ROE 9.7%
Gross mgn 32%
Net mgn 6.7%
Debt/EBITDA 1.1x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 June 2026
All Executives285 Thresholds0 Prospectus0 Other0
Declarations 285 total
▼ President and Chief Operating · Executives · 22 Jun 2026
288 shares Common Stock SEC:0001437749-26-021450:0
◆ Director · Executives · 10 Jun 2026
1,449 shares Common Stock SEC:0001437749-26-020315:0
◆ Director · Executives · 10 Jun 2026
1,449 shares Common Stock SEC:0001437749-26-020317:0
◆ Director · Executives · 10 Jun 2026
1,449 shares Common Stock SEC:0001437749-26-020318:0
◆ Director · Executives · 10 Jun 2026
1,449 shares Common Stock SEC:0001437749-26-020319:0
◆ Director · Executives · 10 Jun 2026
1,449 shares Common Stock SEC:0001437749-26-020320:0
◆ Director · Executives · 10 Jun 2026
1,449 shares Common Stock SEC:0001437749-26-020321:0
◆ Director · Executives · 10 Jun 2026
1,449 shares Common Stock SEC:0001437749-26-020322:0
▼ Director · Executives · 21 May 2026
250 shares @ US$93.00 0.0012% mcap 7.3% of flow Common Stock SEC:0001437749-26-018260:0
▼ Director · Executives · 19 May 2026
250 shares @ US$93.00 0.0012% mcap 7.3% of flow Common Stock SEC:0001437749-26-018105:0
▼ EVP, Chief Development Officer · Executives · 21 Apr 2026
178 shares @ US$93.61 0.0008% mcap 5.4% of flow Common Stock SEC:0001437749-26-013038:0
▼ EVP, CCO and Quality Officer · Executives · 2 Mar 2026
224 shares @ US$102.15 5.9% of flow Common Stock SEC:0001437749-26-006622:0
▼ EVP, CCO and Quality Officer · Executives · 24 Feb 2026
437 shares @ US$106.99 12.0% of flow Common Stock SEC:0001437749-26-005888:0
▼ EVP, Chief HR Officer · Executives · 24 Feb 2026
567 shares @ US$107.35 5.9% of flow Common Stock SEC:0001437749-26-005887:0
▼ EVP, Chief Development Officer · Executives · 24 Feb 2026
350 shares @ US$107.14 10.7% of flow Common Stock SEC:0001437749-26-005886:0
▼ EVP, Chief Information Officer · Executives · 24 Feb 2026
592 shares @ US$107.35 2.4% of flow Common Stock SEC:0001437749-26-005885:0
▼ EVP, Chief Strategy Officer · Executives · 24 Feb 2026
704 shares @ US$107.35 4.8% of flow Common Stock SEC:0001437749-26-005883:0
▼ EVP, Chief Govt Rel Officer · Executives · 24 Feb 2026
733 shares @ US$106.98 4.7% of flow Common Stock SEC:0001437749-26-005882:0
▼ EVP, Chief Legal Officer · Executives · 24 Feb 2026
817 shares @ US$106.98 3.2% of flow Common Stock SEC:0001437749-26-005881:0
▼ EVP, Chief Financial Officer · Executives · 24 Feb 2026
2,041 shares @ US$106.98 4.8% of flow Common Stock SEC:0001437749-26-005880:0
▼ Chairman and CEO · Executives · 24 Feb 2026
4,988 shares @ US$106.98 4.1% of flow Common Stock SEC:0001437749-26-005879:0
▼ Chairman and CEO · Executives · 23 Feb 2026
4,535 shares @ US$114.91 4.6% of flow Common Stock SEC:0001437749-26-005315:1
▼ EVP, Chief Financial Officer · Executives · 23 Feb 2026
1,858 shares @ US$114.91 4.9% of flow Common Stock SEC:0001437749-26-005321:1
▼ EVP, Chief Legal Officer · Executives · 23 Feb 2026
737 shares @ US$114.91 3.2% of flow Common Stock SEC:0001437749-26-005322:1
▼ EVP, Chief Govt Rel Officer · Executives · 23 Feb 2026
666 shares @ US$114.91 6.5% of flow Common Stock SEC:0001437749-26-005323:1
25 of 285 declarations
Load more (260 remaining) 关于 Addus HomeCare Corp Addus HomeCare Corp.(股票代码:ADUS)是一家总部位于美国的家庭护理服务公司,在美国纳斯达克上市。对于法语投资者而言,它最好被视为一家专业的医疗保健服务提供商,其业务领域受到长期人口和政策趋势的支持:人口老龄化、患者对居家护理的偏好,以及公共和私人支付方在降低急性后期和慢性护理成本方面持续面临的压力。Addus 经营三个核心业务线:个人护理、临终关怀和居家健康。其服务主要在患者家中提供,通过与联邦、州和地方政府机构、管理式医疗组织、商业保险公司和个人签订协议。其消费者基础中有相当一部分是“双重符合条件”的,这意味着受益人同时符合Medicare和Medicaid的条件。
该公司起源于1979年,当时它开始提供家庭护理服务。Addus于2006年7月在特拉华州注册成立,并于2009年10月完成首次公开募股。随着时间的推移,该公司通过有机增长和收购相结合的方式扩大了其业务范围。其公司总部位于德克萨斯州弗里斯科,并在伊利诺伊州唐纳斯格罗夫设有一个支持中心。截至2024年底,Addus通过约258个办事处为23个州的客户提供服务,这使其拥有多元化但仍侧重于区域的运营基础。
从竞争角度来看,Addus通过本地密度、支付方关系和临床能力的逐步扩展来区分自身。管理层的策略是深化在现有州的业务,同时增加临床护理服务以补充个人护理。在选定的市场中,该公司现在提供所有三个级别的护理,这可以改善患者保留率、转诊关系和交叉销售机会。这种模式在居家护理中尤为重要,因为规模、报销管理和本地执行至关重要。2024年,Addus报告净服务收入为1.15 billion美元,其中个人护理占收入的最大份额,其次是临终关怀和居家健康。该公司在当年为大约105,000名独立消费者提供了服务。
最近的发展突显了该公司以收购为主导的增长战略。2024年12月2日,Addus完成了对Gentiva个人护理业务的收购,这项交易增强了其市场密度,尤其是在德克萨斯州。2025年,它通过收购Helping Hands Home Care Service继续扩张。最近,在2026年初,Addus报告了强劲的2025年全年业绩,并强调了支持性的州政府资助趋势,包括德克萨斯州自2025年9月1日起生效的显著费率上调。总体而言,ADUS作为一家纳斯达克上市的美国居家护理平台脱颖而出,其业务受益于持久的结构性需求、经常性的报销关系和经过验证的收购战略。